Literature DB >> 2702771

Cyclosporin A enhances elimination of intracellular L. major parasites by murine macrophages.

C Bogdan1, H Streck, M Röllinghoff, W Solbach.   

Abstract

In this study we analyzed the influence of cyclosporin A (CyA) on the process of phagocytosis of L. major promastigotes and amastigotes by inflammatory peritoneal macrophages (MP) from BALB/c mice. Our data clearly demonstrate that CyA profoundly enhanced the degradation by peritoneal MP of both intracellular L. major promastigotes and amastigotes. This effect was T cell-independent and specifically associated with CyA, since the similarly structured cyclosporin F (CyF) was ineffective. CyA did not alter the replication and infectivity of extracellular parasites. From these results we conclude that the inhibition of intracellular parasite replication in the presence of CyA substantially contributes to the previously described suppressive effect of CyA on the development of L. major-induced lesions in BALB/c mice.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2702771      PMCID: PMC1541875     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

1.  Antimalarial activity of cyclosporin A.

Authors:  K Thommen-Scott
Journal:  Agents Actions       Date:  1981-12

2.  Filaricidal effects of cyclosporin-A against Dipetalonema viteae in Mastomys natalensis.

Authors:  D Bout; A Haque; A Capron
Journal:  Trans R Soc Trop Med Hyg       Date:  1984       Impact factor: 2.184

3.  Stage-selective inhibition of rodent malaria by cyclosporine.

Authors:  J R Murphy; S Baqar; R H Baker; E Roberts; S P Nickell; G A Cole
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

4.  Cyclosporin A inhibits lymphokine production but not the responses of macrophages to lymphokines.

Authors:  A W Thomson; D K Moon; C L Geczy; D S Nelson
Journal:  Immunology       Date:  1983-02       Impact factor: 7.397

Review 5.  The immunobiology of leishmaniasis.

Authors:  R D Pearson; D A Wheeler; L H Harrison; H D Kay
Journal:  Rev Infect Dis       Date:  1983 Sep-Oct

6.  Inhibition of T-cell activity by cyclosporin A.

Authors:  L Andrus; K J Lafferty
Journal:  Scand J Immunol       Date:  1981-05       Impact factor: 3.487

7.  Cyclosporin A inhibits the production of gamma interferon (IFN gamma), but does not inhibit production of virus-induced IFN alpha/beta.

Authors:  V K Kalman; G R Klimpel
Journal:  Cell Immunol       Date:  1983-05       Impact factor: 4.868

8.  Inhibition by cyclosporin A of rodent malaria in vivo and human malaria in vitro.

Authors:  S P Nickell; L W Scheibel; G A Cole
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

9.  Cyclosporin A inhibits antigen- and lectin-induced but not constitutive production of interleukin 3.

Authors:  R Palacios
Journal:  Eur J Immunol       Date:  1985-02       Impact factor: 5.532

10.  Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2.

Authors:  D Bunjes; C Hardt; M Röllinghoff; H Wagner
Journal:  Eur J Immunol       Date:  1981-08       Impact factor: 5.532

View more
  5 in total

1.  Characterization of the Protein Tyrosine Phosphatase LmPRL-1 Secreted by Leishmania major via the Exosome Pathway.

Authors:  Sabine Leitherer; Joachim Clos; Elisabeth M Liebler-Tenorio; Ulrike Schleicher; Christian Bogdan; Didier Soulat
Journal:  Infect Immun       Date:  2017-07-19       Impact factor: 3.441

2.  Characterization of anti-Toxoplasma activity of SDZ 215-918, a cyclosporin derivative lacking immunosuppressive and peptidyl-prolyl-isomerase-inhibiting activity: possible role of a P glycoprotein in Toxoplasma physiology.

Authors:  J A Silverman; M L Hayes; B J Luft; K A Joiner
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

3.  Protective effect of isoprinosine in genetically susceptible BALB/c mice infected with Leishmania major.

Authors:  E Cillari; M Dieli; P Lo Campo; G Sireci; A Caffarelli; E Maltese; S Millott; S Milano; F Y Liew
Journal:  Immunology       Date:  1991-09       Impact factor: 7.397

4.  Leishmania major parasites express cyclophilin isoforms with an unusual interaction with calcineurin.

Authors:  C Rascher; A Pahl; A Pecht; K Brune; W Solbach; H Bang
Journal:  Biochem J       Date:  1998-09-15       Impact factor: 3.857

5.  Cyclosporin A treatment of Leishmania donovani reveals stage-specific functions of cyclophilins in parasite proliferation and viability.

Authors:  Wai-Lok Yau; Thierry Blisnick; Jean-François Taly; Manuela Helmer-Citterich; Cordelia Schiene-Fischer; Olivier Leclercq; Jing Li; Dirk Schmidt-Arras; Miguel A Morales; Cedric Notredame; Daniel Romo; Philippe Bastin; Gerald F Späth
Journal:  PLoS Negl Trop Dis       Date:  2010-06-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.